EcoR1 Capital’s Agios Pharmaceuticals AGIO Stock Holding History

EcoR1 Capital’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-172,952	Closed	-$14.1M	–	34
2018 Q1	$14.1M	Buy	+172,952	New	+$13.4M	1.42%	17
2017 Q3	–	Sell	-23,300	Closed	-$1.2M	–	40
2017 Q2	$1.2M	Hold	23,300	–	–	0.21%	30
2017 Q1	$1.36M	Hold	23,300	–	–	0.34%	23
2016 Q4	$972K	Sell	23,300 -176,700	-88%	-$9.27M	0.31%	25
2016 Q3	$10.6M	Buy	+200,000	New	+$8.71M	3.24%	12

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

EcoR1 Capital's AGIO Position: Q2 2018 in Review

EcoR1 Capital sold out of Agios Pharmaceuticals (AGIO) in Q2 2018, closing a stake of 172,952 shares — an estimated $14.1M sold.

EcoR1 Capital first reported a position in AGIO in Q3 2016 and held it in 5 quarters. The position peaked at $14.1M in Q1 2018. 217 funds tracked by Wall St. Rank hold AGIO as of Q2 2018.

EcoR1 Capital reported no remaining Agios Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
EcoR1 Capital sold 172,952 Agios Pharmaceuticals shares in Q2 2018, an estimated $14.1M.
EcoR1 Capital first reported a position in Agios Pharmaceuticals in Q3 2016 and held it in 5 quarters.
EcoR1 Capital's Agios Pharmaceuticals position peaked at $14.1M in Q1 2018.
217 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2018.

Based on EcoR1 Capital's 13F filing for Q2 2018, filed 14 Aug 2018.